Human Genome Epidemiology Literature Finder
Pharmacogenomics
Records 1 - 30 (of 103 Records) |
Query Trace: Ritonavir[original query] |
---|
Hepatic decompensation during paritaprevir/ritonavir/ombitasvir/dasabuvir treatment for genotype 1b chronic hepatitis C patients with advanced fibrosis and compensated cirrhosis. PloS one 2018 8 13 (8): e0202777. Hsieh Yi-Chung, Jeng Wen-Juei, Huang Chien-Hao, Teng Wei, Chen Wei-Ting, Chen Yi-Cheng, Lin Shi-Ming, Tai Dar-In, Lin Chun-Yen, Sheen I-Shy |
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA). BMC infectious diseases 2018 8 18 (1): 357. Taramasso Lucia, Tatarelli Paola, Ricci Elena, Madeddu Giordano, Menzaghi Barbara, Squillace Nicola, De Socio Giuseppe Vittorio, Martinelli Canio, Gulminetti Roberto, Maggi Paolo, Orofino Giancarlo, Vichi Francesca, Di Biagio Antonio, Bonfanti Paolo, |
Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight). The Journal of antimicrobial chemotherapy 2018 6 73 (8): 2129-2136. Molina Jean-Michel, Gallien Sebastien, Chaix Marie-Laure, El Abbassi El Mountacer, Madelaine Isabelle, Katlama Christine, Valin Nadia, Delobel Pierre, Desseaux Kristell, Peytavin Gilles, Saillard Juliette, Raffi François, Chevret Sylvie, |
Pharmacokinetics of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir in Healthy Chinese Subjects and HCV GT1b-Infected Chinese, South Korean and Taiwanese Patients. European journal of drug metabolism and pharmacokinetics 2018 Jun . Zha Jiuhong, Ding Bifeng, Wang Haoyu, Zhao Weihan, Yu Chen, Alves Katia, Mobashery Niloufar, Luo Yan, Menon Rajeev |
Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens. PloS one 2018 13 (5): e0198296. Vasanthakumar Aparna, Davis Justin W, Abunimeh Manal, Söderholm Jonas, Zha Jiuhong, Dumas Emily O, Cohen Daniel E, Waring Jeffrey F, Lagging Mart |
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis. Infection 2018 5 46 (5): 607-615. Ascione Antonio, De Luca Massimo, Melazzini Mario, Montilla Simona, Trotta Maria Paola, Petta Salvatore, Puoti Massimo, Sangiovanni Vincenzo, Messina Vincenzo, Bruno Savino, Izzi Antonio, Villa Erica, Aghemo Alessio, Zignego Anna Linda, Orlandini Alessandra, Fontanella Luca, Gasbarrini Antonio, Marzioni Marco, Giannini Edoardo G, Craxì Antonio, |
Pharmacokinetic Changes during Pregnancy According to Genetic Variants: a Prospective Study in HIV-Infected Patients Receiving Atazanavir-Ritonavir. Antimicrobial agents and chemotherapy 2018 May . Focà Emanuele, Calcagno Andrea, Bonito Andrea, Cusato Jessica, Domenighini Elisabetta, D'Avolio Antonio, Quiros Roldan Eugenia, Trentini Laura, Castelnuovo Filippo, Di Perri Giovanni, Castelli Francesco, Bonora Stefa |
Individualized Protease Inhibitor Monotherapy: The Role of Pharmacokinetics and Pharmacogenetics in an Aged and Heavily Treated HIV-Infected Patient. Clinical drug investigation 2019 8 39 (11): 1125-1131. López Aspiroz Elena, Cabrera Figueroa Salvador Enrique, Valverde Merino María Paz, Carracedo Álvarez Áng |
HIV Drug Efavirenz Inhibits CYP21A2 Activity with Possible Clinical Implications. Hormone research in paediatrics 2019 7 91 (4): 262-270. Malikova Jana, Zingg Tanja, Fingerhut Ralph, Sluka Susanna, Grössl Michael, Brixius-Anderko Simone, Bernhardt Rita, McDougall Jane, Pandey Amit V, Flück Christa |
Adjuvant ribavirin and longer direct-acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failure. Journal of viral hepatitis 2019 6 26 (10): 1210-1217. Lu Mei, Wu Kuan-Han, Li Jia, Moorman Anne C, Spradling Philip R, Teshale Eyasu H, Boscarino Joseph A, Daida Yihe G, Schmidt Mark A, Rupp Loralee B, Zhang Talan, Trudeau Sheri, Gordon Stuart |
IL28B gene polymorphism is correlated with changes in low-density lipoprotein cholesterol levels after clearance of hepatitis C virus using direct-acting antiviral treatment. Journal of gastroenterology and hepatology 2019 May . Morihara Daisuke, Ko Yi-Ling, Shibata Kumiko, Yamauchi Ryo, Fukuda Hiromi, Tsuchiya Naoaki, Fukunaga Atsushi, Kunimoto Hideo, Iwashita Hideyuki, Takata Kazuhide, Tanaka Takashi, Sakurai Kunitoshi, Inomata Shinjiro, Yokoyama Keiji, Nishizawa Shinya, Takeyama Yasuaki, Irie Makoto, Shakado Satoshi, Sohda Tetsuro, Sakisaka Shota |
Contribution of Genetic Background and Data Collection on Adverse Events of Anti-human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration Rate. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019 Apr . Dietrich Léna G, Barceló Catalina, Thorball Christian W, Ryom Lene, Burkhalter Felix, Hasse Barbara, Furrer Hansjakob, Weisser Maja, Steffen Ana, Bernasconi Enos, Cavassini Matthias, de Seigneux Sophie, Csajka Chantal, Fellay Jacques, Ledergerber Bruno, Tarr Philip |
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial. The Journal of antimicrobial chemotherapy 2019 Nov . Dickinson Laura, Gurjar Rohan, Stöhr Wolfgang, Bonora Stefano, Owen Andrew, D'Avolio Antonio, Cursley Adam, Molina Jean-Michel, Fäetkenheuer Gerd, Vandekerckhove Linos, Di Perri Giovanni, Pozniak Anton, Richert Laura, Raffi François, Boffito Marta, |
Highly effective treatment response and well tolerability by all oral direct acting antivirals for chronic hepatitis C patients post organ transplantation. Journal of the Chinese Medical Association : JCMA 2019 11 83 (1): 18-24. Wu Sih-Hsien, Loong Che-Chuan, Chu Chi-Jen, Su Chien-Wei, Lin Chung-Chi, Hsia Cheng-Yuan, Liu Chinsu, Lee Shou-Dong, Wang Yuan-Jen, Lee Fa-Yauh, Linb Niang-Cheng, Chen Cheng-Yen, Huang Yi-Hsiang, Hou Ming-Ch |
Efficacy, Safety, and Predictors of Direct-acting antivirals in Hepatitis C Virus Patients with Heterogeneous Liver Diseases. The new microbiologica 2019 10 42 (4): 189-196. De Pace Vanessa, Morelli Maria Cristina, Ravaioli Matteo, Maggi Fabrizio, Galli Silvia, Vero Vittoria, Re Maria Carla, Cescon Matteo, Pistello Mau |
Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C. Journal of clinical and translational hepatology 2019 10 7 (3): 221-225. Wei Lai, Shang Jia, Ma Yuanji, Xu Xiaoyuan, Huang Yan, Guan Yujuan, Duan Zhongping, Zhang Wenhong, Gao Zhiliang, Zhang Mingxiang, Li Jun, Jia Jidong, Yang Yongfeng, Wen Xiaofeng, Wang Maorong, Jia Zhansheng, Ning Bo, Chen Yongping, Qi Yue, Du Jie, Jiang Jianning, Tong Lixin, Xie Yao, Wu Jinzi |
Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis. Virology journal 2019 1 16 (1): 11. Wu Jingjing, Huang Peng, Fan Haozhi, Tian Ting, Xia Xueshan, Fu Zuqiang, Wang Yan, Ye Xiangyu, Yue Ming, Zhang Y |
Impact of IL28B gene polymorphism on efficacy and safety of direct acting antivirals in hepatitis C Egyptian patients. International journal of clinical pharmacy 2020 Jul . Ebid Abdel-Hameed Ibrahim Mohamed, Ahmed Ossama Ashraf, Agwa Sara Hassan, Abdel-Motaleb Sara Mohamed, Hagag Radwa Sam |
Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives. Pharmacogenetics and genomics 2020 Feb . Haas David W, Cramer Yoninah S, Godfrey Catherine, Rosenkranz Susan L, Aweeka Francesca, Berzins Baiba, Coombs Robert, Coughlin Kristine, Moran Laura E, Gingrich David, Zorrilla Carmen D, Baker Paxton, Cohn Susan E, Scarsi Kimberly K, |
Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations. Journal of medical biochemistry 2020 Oct 39 (4): 488-499. Stankovi? Biljana, Kotur Nikola, Gaši? Vladimir, Klaassen Kristel, Ristivojevi? Bojan, Stojiljkovi? Maja, Pavlovi? Sonja, Zuki? Bran |
Retreatment of patients with chronic hepatitis C, subtype 1b and cirrhosis, who failed previous direct-acting antiviral therapy including first- and second-generation NS5A inhibitors with ombitasvir/paritaprevir/ritonavir, dasabuvir + sofosbuvir + ribavirin. Journal of viral hepatitis 2020 1 27 (5): 548-551. Fedorchenko Sergii V, Martynovych Tatiana, Klimenko Zhanna, Yanchenko Vitaliy, Solianyk Iry |
Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study. Viruses 2021 8 13 (7): . Spaziante Martina, Taliani Gloria, Marchetti Giulia, Tavelli Alessandro, Lichtner Miriam, Cingolani Antonella, Cicalini Stefania, Biliotti Elisa, Girardi Enrico, Antinori Andrea, Puoti Massimo, d'Arminio Monforte Antonella, Cozzi-Lepri Alessand |
Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in COVID-19 patients. Pharmacogenomics 2021 3 22 (6): 375-381. Biswas Mohito |
Investigating the influence of relevant pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of orally administered docetaxel combined with ritonavir. The pharmacogenomics journal 2021 3 21 (3): 336-345. van Eijk Maarten, Pluim Dick, Dorlo Thomas P C, Marchetti Serena, Huitema Alwin D R, Beijnen Jos |
Treatment-Experienced Patients on Third-Line Therapy: A Retrospective Cohort of Treatment Outcomes at the HIV Advanced Treatment Centre, University Teaching Hospital, Zambia. AIDS research and human retroviruses 2022 7 38 (10): 798-805. Toeque Mona-Gekanju, Lindsay Brianna, Zulu Paul Msanzya, Hachaambwa Lottie, Fwoloshi Sombo, Chanda Duncan, Stafford Kristen A, Mupeta Francis, Siwingwa Mpanji, Mutinta Melody, Chirwa Lameck, Riedel David J, Claassen Cassidy, Mulenga Llo |
hsa-miR-17-5p: A Possible Predictor of Ombitasvir/Paritaprevir/Ritonavir?+?Dasabuvir?±?Ribavirin Therapy Efficacy in Hepatitis C Infection. Current microbiology 2022 5 79 (6): 186. Öksüz Zehra, Üçbilek Enver, Serin Mehmet Sami, Yara? Serkan, Temel Gülhan Örekici, Sezgin Orh |
Long-term follow-up of HIV-1 multi-drug-resistant treatment-experienced participants treated with etravirine, raltegravir and boosted darunavir: towards drug-reduced regimen? ANRS CO3 Aquitaine Cohort 2007-2018. International journal of antimicrobial agents 2022 12 61 (1): 106696. Nyamankolly Elsa, Bellecave Pantxika, Wittkop Linda, Le Marec Fabien, Duffau Pierre, Lazaro Estibaliz, Vareil Marc-Olivier, Tumiotto Camille, Hessamfar Mojgan, Cazanave Charles, Perrier Adélaïde, Leleux Olivier, Bonnet Fabrice, Neau Didi |
Potential polymorphic CYP1A2 and CYP2D6-mediated pharmacokinetic interactions between risperidone or olanzapine and selected drugs intended to treat COVID-19. Drug metabolism and bioanalysis letters 2022 11 . Rojas-Macetas Ariana, Medalla-Garro Geraldine, Saravia María, Losno Ricardo, Valderrama-Wong Milton, Pariona Ricardo, Alvarado Angel |
MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY. International journal of antimicrobial agents 2023 8 106952. Jon Salmanton-García, Francesco Marchesi, Philipp Koehler, Barbora Weinbergerová, Natasa ?olovi?, Iker Falces-Romero, Caterina Buquicchio, Francesca Farina, Jens VAN Praet, Monika M Biernat, Federico Itri, Lucia Prezioso, Carlo Tascini, Antonio Vena, Alessandra Romano, Mario Delia, Julio Dávila-Valls, Sonia Martín-Pérez, Esperanza Lavilla-Rubira, Tatjana Adži?-Vuki?evi?, Daniel García-Bordallo, Alberto López-García, Mariana Criscuolo, Verena Petzer, Nicola S Fracchiolla, Ildefonso Espigado, Uluhan Sili, Stef Meers, Nurettin Erben, Chiara Cattaneo, Athanasios Tragiannidis, Eleni Gavriilaki, Martin Schönlein, Mirjana Mitrovic, Nikola Pantic, Maria Merelli, Jorge Labrador, José-Ángel Hernández-Rivas, Andreas Glenthøj, Guillemette Fouquet, Maria Ilaria Del Principe, Michelina Dargenio, María Calbacho, Caroline Besson, Milena Kohn, Stefanie Gräfe, Ditte Stampe Hersby, Elena Arellano, Gökçe MelisÇOLAK, Dominik Wolf, Monia Marchetti, Anna Nordlander, Ola Blennow, Raul Cordoba, Bojana Miškovi?, Miloš Mladenovi?, Martina Bavastro, Alessandro Limongelli, Laman Rahimli, Livio Pagano, Oliver A Corne |
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records. Antimicrobial agents and chemotherapy 2023 4 e0233918. Julie Bertrand, Aurélie Barrail-Tran, Lucie Fayette, Rada Savic, Cécile Goujard, Elina Teicher, Caroline Barau, Alain Pruvost, Anne-Marie Taburet, France Mentré, Céline Verstuy |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: